Montreal, Quebec
February 11-12, 2016
This event will explore a variety of issues associated with the commercialization of non-invasive prenatal testing (NIPT), such as the desire to innovate, commercialization pressure, patient access to new technologies, and the development of new health policy concerns.
Specific goals are to:
- explore the history and unique issues associated with the IP and commercialization of NIPT
- analyze the commercialization impact of and future challenges associated with NIPT; and
- produce a policy document on point.